Gudula J.A.M. Boon

1.6k total citations · 1 hit paper
20 papers, 804 citations indexed

About

Gudula J.A.M. Boon is a scholar working on Internal Medicine, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Gudula J.A.M. Boon has authored 20 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Internal Medicine, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Gudula J.A.M. Boon's work include Venous Thromboembolism Diagnosis and Management (16 papers), Pulmonary Hypertension Research and Treatments (13 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Gudula J.A.M. Boon is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (16 papers), Pulmonary Hypertension Research and Treatments (13 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Gudula J.A.M. Boon collaborates with scholars based in Netherlands, Belgium and Switzerland. Gudula J.A.M. Boon's co-authors include Frederikus A. Klok, Stefano Barco, Bob Siegerink, Martijn A. Spruit, J.J. Miranda Geelhoed, Matthias Endres, Spencer Rezek, Jörg Janne Vehreschild, Samuel Knauß and Menno V. Huisman and has published in prestigious journals such as PLoS ONE, European Respiratory Journal and Thorax.

In The Last Decade

Gudula J.A.M. Boon

20 papers receiving 778 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19

2020 394 citations Frederikus A. Klok, Gudula J.A.M. Boon et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gudula J.A.M. Boon Netherlands	13	361	306	223	204	190	20	804
Trudy Millard Krause United States	11	41 0.1×	278 0.9×	136 0.6×	217 1.1×	116 0.6×	38	647
Marco Loffi Italy	12	251 0.7×	133 0.4×	73 0.3×	147 0.7×	32 0.2×	24	699
Samanjit S Hare United Kingdom	11	534 1.5×	18 0.1×	319 1.4×	62 0.3×	142 0.7×	19	970
Luis Enrique Colunga‐Lozano Mexico	11	95 0.3×	77 0.3×	36 0.2×	60 0.3×	26 0.1×	28	540
Luca Zanin Italy	8	332 0.9×	29 0.1×	78 0.3×	38 0.2×	45 0.2×	22	639
Ara Ko United States	14	109 0.3×	110 0.4×	56 0.3×	109 0.5×	103 0.5×	56	583
Fahad Faqihi Saudi Arabia	15	293 0.8×	34 0.1×	108 0.5×	28 0.1×	110 0.6×	35	660
Navdeep Sangha United States	12	147 0.4×	103 0.3×	167 0.7×	81 0.4×	37 0.2×	34	422
Alina Andras United Kingdom	11	53 0.1×	165 0.5×	130 0.6×	97 0.5×	19 0.1×	22	548
Lisa Spencer United Kingdom	14	190 0.5×	13 0.0×	644 2.9×	40 0.2×	58 0.3×	45	931

Countries citing papers authored by Gudula J.A.M. Boon

Since Specialization

Citations

This map shows the geographic impact of Gudula J.A.M. Boon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gudula J.A.M. Boon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gudula J.A.M. Boon more than expected).

Fields of papers citing papers by Gudula J.A.M. Boon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gudula J.A.M. Boon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gudula J.A.M. Boon. The network helps show where Gudula J.A.M. Boon may publish in the future.

Co-authorship network of co-authors of Gudula J.A.M. Boon

This figure shows the co-authorship network connecting the top 25 collaborators of Gudula J.A.M. Boon. A scholar is included among the top collaborators of Gudula J.A.M. Boon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gudula J.A.M. Boon. Gudula J.A.M. Boon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jong, Cindy M.M. de, et al.. (2023). The Post–Venous Thromboembolism Functional Status Scale: From Call to Action to Application in Research, Extension to COVID-19 Patients, and Its Use in Clinical Practice. Seminars in Thrombosis and Hemostasis. 49(7). 764–773. 9 indexed citations

Zhai, Zhiwei, Gudula J.A.M. Boon, Marius Staring, et al.. (2023). Automated quantification of the pulmonary vasculature in pulmonary embolism and chronic thromboembolic pulmonary hypertension. Pulmonary Circulation. 13(2). e12223–e12223. 3 indexed citations

Boon, Gudula J.A.M., Yvonne M. Ende-Verhaar, Marion Delcroix, et al.. (2022). Diagnostic efficacy of ECG-derived ventricular gradient for the detection of chronic thromboembolic pulmonary hypertension in patients with acute pulmonary embolism. Journal of Electrocardiology. 74. 94–100. 3 indexed citations

Boon, Gudula J.A.M., Wilbert B. van den Hout, Stefano Barco, et al.. (2021). A model for estimating the health economic impact of earlier diagnosis of chronic thromboembolic pulmonary hypertension. ERJ Open Research. 7(3). 719–2020. 13 indexed citations

Boon, Gudula J.A.M., Cornelis J. van Rooden, Yvonne M. Ende-Verhaar, et al.. (2021). Identification of chronic thromboembolic pulmonary hypertension on CTPAs performed for diagnosing acute pulmonary embolism depending on level of expertise. European Journal of Internal Medicine. 93. 64–70. 18 indexed citations

Boon, Gudula J.A.M., Yvonne M. Ende-Verhaar, Marion Delcroix, et al.. (2021). Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the InShape II study. Thorax. 76(10). 1002–1009. 39 indexed citations

Boon, Gudula J.A.M., Frances S. de Man, Josien van Es, et al.. (2021). Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension. European Respiratory Journal. 58(6). 2100699–2100699. 19 indexed citations

Boon, Gudula J.A.M., Stefano Barco, Harm Jan Bogaard, et al.. (2021). Efficacy and safety of a 12-week outpatient pulmonary rehabilitation program in Post-PE Syndrome. Thrombosis Research. 206. 66–75. 30 indexed citations

Boon, Gudula J.A.M., Yvonne M. Ende-Verhaar, Ludo F.M. Beenen, et al.. (2021). Prediction of chronic thromboembolic pulmonary hypertension with standardised evaluation of initial computed tomography pulmonary angiography performed for suspected acute pulmonary embolism. European Radiology. 32(4). 2178–2187. 26 indexed citations

10.

Boon, Gudula J.A.M., Menno V. Huisman, & Frederikus A. Klok. (2021). Determinants and Management of the Post–Pulmonary Embolism Syndrome. Seminars in Respiratory and Critical Care Medicine. 42(2). 299–307. 28 indexed citations

11.

Klok, Frederikus A., Gudula J.A.M. Boon, Stefano Barco, et al.. (2020). The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. European Respiratory Journal. 56(1). 2001494–2001494. 394 indexed citations breakdown →

12.

Boon, Gudula J.A.M., Harm Jan Bogaard, & Frederikus A. Klok. (2020). Essential aspects of the follow‐up after acute pulmonary embolism: An illustrated review. Research and Practice in Thrombosis and Haemostasis. 4(6). 958–968. 30 indexed citations

13.

Boon, Gudula J.A.M., Nienke van Rein, Harm Jan Bogaard, et al.. (2020). Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism. PLoS ONE. 15(4). e0232354–e0232354. 5 indexed citations

14.

Dam, Lisette F. van, Lucia J.M. Kroft, Gudula J.A.M. Boon, et al.. (2020). Computed tomography pulmonary perfusion imaging and 3-months clinical outcomes after acute pulmonary embolism. Thrombosis Research. 199. 32–34. 7 indexed citations

15.

Boon, Gudula J.A.M., Stefano Barco, Laurent Bertoletti, et al.. (2020). Measuring functional limitations after venous thromboembolism: Optimization of the Post-VTE Functional Status (PVFS) Scale. Thrombosis Research. 190. 45–51. 48 indexed citations

16.

Boon, Gudula J.A.M., Menno V. Huisman, & Frederikus A. Klok. (2020). Why, Whom, and How to Screen for Chronic Thromboembolic Pulmonary Hypertension after Acute Pulmonary Embolism. Seminars in Thrombosis and Hemostasis. 47(6). 692–701. 10 indexed citations

17.

Ende-Verhaar, Yvonne M., Lilian J. Meijboom, Lucia J.M. Kroft, et al.. (2019). Usefulness of standard computed tomography pulmonary angiography performed for acute pulmonary embolism for identification of chronic thromboembolic pulmonary hypertension: results of the InShape III study. The Journal of Heart and Lung Transplantation. 38(7). 731–738. 53 indexed citations

18.

Boon, Gudula J.A.M., et al.. (2018). Management and treatment of deep vein thrombosis in special populations. Expert Review of Hematology. 11(9). 685–695. 22 indexed citations

19.

Boon, Gudula J.A.M.. (2015). Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?. World Journal of Gastroenterology. 21(40). 11469–11469. 45 indexed citations

20.

Ecollan, Patrick, et al.. (2005). [Value of biochemistry performed in pre-hospital cardiology].. PubMed. 98(11). 1111–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact